Wilmington, DE -- (SBWIRE) -- 02/26/2014 -- Equity Profile Report expands its NYSE Gainers Weekly Watch List adding Actavis plc (NYSE:ACT) and ConocoPhillips (NYSE:COP).
Actavis plc (NYSE:ACT) an integrated specialty pharmaceutical company that develops, manufactures, markets, and distributes pharmaceutical products in the United States, Canada, and internationally closed up in its previous session (+1.18%) on 3,425,110 shares traded after ACTAVIS PLC Filed SEC form 10-K, Annual Report. Actavis plc (NYSE:ACT) is currently up (+172.16%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NYSE Gainers Watch List.
Click Here to find out what other Investors are saying about Actavis plc (NYSE:ACT)
ConocoPhillips (NYSE:COP) a company that explores for, produces, transports, and markets crude oil, bitumen, natural gas, liquefied natural gas, and natural gas liquids on a worldwide basis closed up in its previous session (+0.15%) on 5,871,703 shares traded after CONOCOPHILLIPS Filed SEC form 10-K, Annual Report. ConocoPhillips (NYSE:COP) is currently up (+18.57%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NYSE Gainers Watch List.
Click Here to find out what other Investors are saying about ConocoPhillips (NYSE:COP)
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Equityprofilereport.com
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Equity Profile Report